← Eichor
Study identifier: NCT07691463 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Evaluating How Well Different Types of Light-sensitive Cells in the Eye Contribute to Its Focusing Ability

Condition: Monochromatic · L- and S-cone Modulation Only · L- and M-cone Modulation Only  ·  Sponsor: Rochester Institute of Technology

PhaseNA
Planned participants20
Who can joinAll sexes, N/A to 35 Years
Healthy volunteersYes

About this study

In this experiment, subjects will view shapes on a screen with varying colors and be asked to focus their eyes on the shapes. The shapes will look as though they are jumping to random distances away from the eye. As the subjects focus their eyes on the shapes, the investigators will measure the focus of their eyes using a device called a wavefront sensor. This device uses infrared light to measure the optical properties of the eye in real time. Our goal is to find out how well the eye focuses on different colors. Our broad goal is to better understand how the eye focuses because that process is a major part of having clear and good vision.

This description comes directly from the study's public registry record.

Talk to the study team

Benjamin M Chin, Doctorate  ·  8454534320  ·  bmccis@rit.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Chester F. Carlson Center for Imaging ScienceRochester, New York, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07691463